Intrahepatic CD69(+)Vδ1 T cells re-circulate in the blood of patients with metastatic colorectal cancer and limit tumor progression.
Bruni E
J Immunother Cancer. 10(7)doi: 10.1136/jitc-2022-004579
Irrelevance of microsatellite instability in the epidemiology of sporadic pancreatic ductal adenocarcinoma.
Laghi L
PLoS One. 2012 Sep 21;7(9):e46002. doi: 10.1371/journal.pone.0046002
Immunotherapeutic early-phase clinical trials and malignant gliomas: A single-center experience and comprehensive immunophenotyping of circulating leukocytes.
Simonelli M
Neurooncol Adv. 2021 Nov 13;3(1):vdab160. doi: 10.1093/noajnl/vdab160
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsies.
Petrillo M
Ann Oncol. 2016 Jan 17;27(4):625-34. doi: 10.1093/annonc/mdw007
Inhibition of tumor-associated macrophages by trabectedin improves the antitumor adaptive immunity in response to anti-PD-1 therapy.
Belgiovine C
Eur J Immunol. 2021 Oct 8;51(11):2677-2686. doi: 10.1002/eji.202149379
Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4.
Colotta F
Science. 261(5120):472-5.
Inhibition of interleukin-1 responsiveness by type II receptor gene transfer: a surface “receptor” with anti-interleukin-1 function.
Re F
J Exp Med. 183(4):1841-50.
Interleukin 10 increases CCR5 expression and HIV infection in human monocytes.
Sozzani S
J Exp Med. 187(3):439-44.
Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family.
Garlanda C
Proc Natl Acad Sci U S A. 2004 Mar 1;101(10):3522-6.
Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene.
Borrello MG
Proc Natl Acad Sci U S A. 2005 Oct 3;102(41):14825-30.